Ameliorative effects of melatonin on intestinal oxidative damage in streptozotocin-induced diabetic rats

Creative Commons License

Çevikelli Yakut Z. A. , Akçay G. B. , Çevik Ö., Şener G.

İstanbul Journal of Pharmacy, vol.51, pp.1-8, 2020 (Journal Indexed in ESCI)

  • Publication Type: Article / Article
  • Volume: 51
  • Publication Date: 2020
  • Doi Number: 10.26650/istanbuljpharm.2020.0078
  • Title of Journal : İstanbul Journal of Pharmacy
  • Page Numbers: pp.1-8


Background and Aims: The potential therapeutic effects of melatonin on changes in intestinal tissue of diabetic rats were


Methods: AMale Sprague-Dawley rats were assigned into 5 groups (10 rats in each): Control, diabetes, diabetes+insulin,

diabetes+melatonin, and diabetes+insulin+melatonin groups. Streptozotocin (60 mg/kg) was administered intraperitoneally

to the rats to induce diabetes. At the end of 8 weeks of treatment, after blood glucose measurement and subsequent decapitation,

glutathione (GSH) and malondialdehyde (MDA) levels and caspase-3, myeloperoxidase (MPO), and superoxide

dismutase (SOD) activities in the intestinal tissue were investigated.

Results: In diabetic animals, elevated blood glucose levels caused oxidant damage in the intestinal tissue that was demonstrated

with increased MDA levels, caspase and MPO activities, and decreased GSH levels and SOD activities. Although melatonin

demonstrated more significant results than insulin, separate administration of both melatonin and insulin improved the

oxidative damage parameters compared to the diabetes group. In the combined treatment group, all parameters were back to

control levels statistically more significant when compared with the treatment-alone.

Conclusion: Melatonin has been shown to protect intestinal tissue from diabetic oxidant damage. With insulin treatment in

type I diabetes, melatonin supplements may increase the quality of life through reducing complications.